Medicinova (MNOV) Current Assets (2010 - 2026)
Medicinova (MNOV) posted quarterly Current Assets of $31.0 million for Q4 2025, down 24.55% year-over-year from $41.1 million in Q4 2024, and down 5.87% quarter-over-quarter from $32.9 million in Q3 2025.
Medicinova (MNOV) Current Assets (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Current Assets for 16 consecutive years, with $31.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 24.55% year-over-year to $31.0 million; the TTM figure through Dec 2025 stood at $31.0 million (down 24.55% YoY), while the FY2025 annual figure was $31.0 million, down 24.55% from the prior year.
- Current Assets slipped to $31.0 million in Q4 2025 per MNOV's latest filing, from $32.9 million in the prior quarter.
- Across five years, Current Assets topped out at $81.5 million in Q1 2021 and bottomed at $31.0 million in Q4 2025.
- Historically, Current Assets has averaged $54.2 million across 5 years, with a median of $53.1 million in 2022.
- Annual changes were most pronounced in 2021 — Current Assets soared 31.05% — and 2022, when it sank 30.21%.
- Medicinova's Current Assets stood at $72.0 million in 2021, then fell by 18.08% to $59.0 million in 2022, then slipped by 13.24% to $51.2 million in 2023, then decreased by 19.74% to $41.1 million in 2024, then dropped by 24.55% to $31.0 million in 2025.
- Business Quant data shows MNOV's Current Assets at $31.0 million in Q4 2025, $32.9 million in Q3 2025, and $35.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Medicinova | 66.94 Mn | 66.94 Mn | 317,759.00 | 25.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.92 Mn |
| Dec 31, 2025 | 30.99 Mn |
| Sep 30, 2025 | 32.92 Mn |
| Jun 30, 2025 | 35.12 Mn |
| Mar 31, 2025 | 37.68 Mn |
| Dec 31, 2024 | 41.07 Mn |
| Sep 30, 2024 | 43.27 Mn |
| Jun 30, 2024 | 45.51 Mn |
| Mar 31, 2024 | 47.86 Mn |
| Dec 31, 2023 | 51.17 Mn |
| Sep 30, 2023 | 53.00 Mn |
| Jun 30, 2023 | 53.52 Mn |
| Mar 31, 2023 | 56.03 Mn |
| Dec 31, 2022 | 58.99 Mn |
| Sep 30, 2022 | 53.15 Mn |
| Jun 30, 2022 | 65.96 Mn |
| Mar 31, 2022 | 68.83 Mn |
| Dec 31, 2021 | 72.01 Mn |
| Sep 30, 2021 | 76.16 Mn |
| Jun 30, 2021 | 78.91 Mn |